Factors Affecting Risk of CVD Events in a Global CVD Prevention Cohort of People with HIV

By sjmartinez • April 27, 2025

Grinspoon SK, Watanabe M, Ribaudo HJ, Bloomfield GS, Fichtenbaum CJ, Umbleja T, Chu SM, Fitch KV, Diggs MR, Zhao S, Looby SE, Currier JS, Aberg JA, Malvestutto CD, Erlandson KM, Martinez E, Asupoto O, Gupta SK, Lopez-Bernaldo de Quiros JC, Nixon D, Bedimo R, Lu MT, Douglas PS, Zanni MV. Factors Affecting Risk of CVD Events in a Global CVD Prevention Cohort of People with HIV. Clin Infect Dis. 2025 Apr 25:ciaf210. doi: 10.1093/cid/ciaf210. Epub ahead of print. PMID: 40281648.

Tags: CVD, HIV, Infectious Diseases, MACE, Publications, REPRIEVE, Women

A spatial transcriptomic atlas of the host response to oropharyngeal candidiasis

Nabeela S, McSwiggin H, Magalhaes RDM, Mattos EC, Mannan M, Dillon JT, Barbarino A, Youssef EG, Singh S, Yan W, Ibrahim AS, Conti HR, Uppuluri[...]

Strain background interacts with chromosome 7 aneuploidy to determine commensal and virulence phenotypes in Candida albicans

Mishra A, Solis NV, Dietz SM, Crouch AL, Filler SG, Anderson MZ. Strain background interacts with chromosome 7 aneuploidy to determine commensal and virulence phenotypes[...]

Preexposure Prophylaxis for HIV: Updated Recommendations From the 2024 International Antiviral Society-USA Panel

Landovitz RJ, Molina JM, Buchbinder SP; International Antiviral Society-USA (IAS-USA) Panel. Preexposure Prophylaxis for HIV: Updated Recommendations From the 2024 International Antiviral Society-USA Panel. JAMA.[...]